Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr;20(4):920-921.
doi: 10.1111/ajt.15741. Epub 2019 Dec 30.

Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway

S Samuel Weigt  1 , Laurie D Snyder  2
Affiliations
Free article
Editorial

Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway

S Samuel Weigt et al. Am J Transplant. 2020 Apr.
Free article
No abstract available

Keywords: antibody biology; editorial/personal viewpoint; lung disease: immune/inflammatory; lung disease: infectious; lung transplantation/pulmonology.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Kulkarni HS, Tsui K, Sunder S, et al. Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation. Am J Transplant. 2019. https://doi.org/10.1111/ajt.15687.
    1. Botha P, Archer L, Anderson RL, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation. 2008;85:771-774.
    1. Gregson AL, Wang X, Weigt SS, et al. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med. 2013;187:518-526.
    1. Kauke T, Kneidinger N, Martin B, et al. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies. Tissue Antigens. 2015;86:178-185.
    1. Lobo LJ, Aris RM, Schmitz J, Neuringer IP. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant. 2013;32:70-77.